FORA Capital LLC Buys New Stake in Alignment Healthcare, Inc. $ALHC

Key Points

• FORA Capital LLC has invested approximately $409,000 in Alignment Healthcare, acquiring 21,976 shares in the first quarter of this year.
• Alignment Healthcare's stock has seen a 1.1% increase recently, with a market cap of $3.23 billion and PE ratio of -58.28.
• Despite a significant revenue increase of 49.0% from the previous year, the company reported a quarterly EPS of $0.07, beating estimates.

FORA Capital LLC purchased a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 21,976 shares of the company's stock, valued at approximately $409,000.

A number of other hedge funds have also recently added to or reduced their stakes in ALHC. Wells Fargo & Company MN boosted its stake in Alignment Healthcare by 58.3% in the 4th quarter. Wells Fargo & Company MN now owns 48,813 shares of the company's stock worth $549,000 after buying an additional 17,985 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth $1,769,000. Barclays PLC increased its holdings in shares of Alignment Healthcare by 3.7% during the 4th quarter. Barclays PLC now owns 200,564 shares of the company's stock worth $2,256,000 after buying an additional 7,118 shares during the last quarter. MetLife Investment Management LLC increased its holdings in shares of Alignment Healthcare by 5.6% during the 4th quarter. MetLife Investment Management LLC now owns 61,344 shares of the company's stock worth $690,000 after buying an additional 3,256 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock worth $119,000 after buying an additional 6,286 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Hyong Kim sold 24,800 shares of Alignment Healthcare stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $16.00, for a total value of $396,800.00. Following the completion of the sale, the insider owned 447,367 shares of the company's stock, valued at approximately $7,157,872. The trade was a 5.25% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Andreas P. Wagner sold 12,032 shares of Alignment Healthcare stock in a transaction on Monday, August 25th. The shares were sold at an average price of $16.47, for a total transaction of $198,167.04. Following the completion of the sale, the insider directly owned 192,043 shares of the company's stock, valued at approximately $3,162,948.21. The trade was a 5.90% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 636,185 shares of company stock worth $9,235,468 in the last 90 days. 6.60% of the stock is owned by corporate insiders.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC traded up $0.37 during mid-day trading on Tuesday, reaching $16.73. The company had a trading volume of 1,162,540 shares, compared to its average volume of 2,990,192. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock has a market cap of $3.31 billion, a PE ratio of -59.62 and a beta of 1.17. Alignment Healthcare, Inc. has a 1-year low of $8.65 and a 1-year high of $21.06. The company has a 50-day moving average price of $13.98 and a two-hundred day moving average price of $15.37.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. During the same quarter in the prior year, the company earned ($0.13) earnings per share. The company's revenue for the quarter was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ALHC. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. KeyCorp raised shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price target for the company in a research report on Monday, August 25th. Barclays raised shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and lifted their price target for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, Alignment Healthcare currently has an average rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.